What can the government do to help get around that hurdle of the commercial reality? You'd hate to see hope in research stifled because of the bottom line that a multinational drug company may have. What role can government play to help with a rare disorder issue?
We actually had an interesting discussion about this last week, but I'd be interested to hear your take.